Exploring Advances in Heart Imaging: Clinical application Keya Medical’s CT FFR – DeepVessel FFR
The world of cardiovascular imaging is evolving rapidly, with groundbreaking technologies offering new ways to diagnose and treat heart diseases. Keith Loria’s article in Radiology Today delves into these advancements, emphasizing the critical role of Artificial Intelligence (AI) in this transformation. Among the featured innovations is Keya Medical’s DeepVessel FFR, a non-invasive AI-driven tool that is reshaping the approach to coronary artery disease. By providing comprehensive insights into both the anatomical and physiological aspects of heart health, DeepVessel FFR is enabling physicians to make more informed, personalized treatment decisions. For a deeper dive into how these technologies are changing the landscape of heart imaging, read the full article on Radiology Today.
Highlighted Topics from “The Depths of the Heart” by Keith Loria in Radiology Today
- Advanced Imaging Technologies:
The article discusses the latest advancements in heart imaging technologies, such as cardiac MRI and CT scans, which are becoming increasingly integral in diagnosing and treating cardiovascular diseases. - AI in Cardiovascular Imaging:
Artificial Intelligence (AI) is revolutionizing heart imaging by improving the accuracy and efficiency of diagnoses. The integration of AI tools in imaging is enhancing the plaque analysis and detection of heart diseases at earlier stages. - DeepVessel FFR in Clinical Practice:
The article highlights the clinical application of technologies like DeepVessel FFR, which offers non-invasive, AI-driven insights into coronary artery disease, enabling more precise treatment planning.
About DEEPVESSEL FFR
DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA). The software processes coronary CTA images semi-automatically, generates a three-dimensional model of the coronary artery tree, and estimates CT FFR values. DEEPVESSEL FFR is FDA-Cleared, CE-Marked, NMPA-Cleared, HSA-Certified.
About Keya Medical
Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. Follow us on LinkedIn, Twitter, and Facebook.
Media Contact
contact@keyamedna.com
Learn more about DEEPVESSEL FFR
We are actively looking for clinical partners in the United States and EMEA.